Cargando…

Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort

Long interspersed nuclear element-1 (LINE-1/L1) retrotransposons make up 17% of the human genome. They represent one class of transposable elements with the capacity to both mobilize autonomously and in trans via the mobilization of other elements, primarily Alu and SVA elements. Reference LINE-1 el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fröhlich, Alexander, Pfaff, Abigail L., Bubb, Vivien J., Quinn, John P., Koks, Sulev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449770/ https://www.ncbi.nlm.nih.gov/pubmed/37620405 http://dx.doi.org/10.1038/s41598-023-41052-1

Ejemplares similares

An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
por: Pfaff, Abigail L., et al.
Publicado: (2020)

Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
por: Pfaff, Abigail L., et al.
Publicado: (2021)

A Genome-Wide Screen for the Exonisation of Reference SINE-VNTR-Alus and Their Expression in CNS Tissues of Individuals with Amyotrophic Lateral Sclerosis
por: Pfaff, Abigail L., et al.
Publicado: (2023)

Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
por: Koks, Sulev, et al.
Publicado: (2021)

Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT Locus
por: Fröhlich, Alexander, et al.
Publicado: (2022)

Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the Transcriptome
por: Koks, Sulev, et al.
Publicado: (2021)

Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
por: Pfaff, Abigail L., et al.
Publicado: (2022)

A polymorphic transcriptional regulatory domain in the amyotrophic lateral sclerosis risk gene CFAP410 correlates with differential isoform expression
por: Marshall, Jack N. G., et al.
Publicado: (2022)

CRISPR deletion of a SINE-VNTR-Alu (SVA_67) retrotransposon demonstrates its ability to differentially modulate gene expression at the MAPT locus
por: Fröhlich, Alexander, et al.
Publicado: (2023)

Variable number tandem repeats – Their emerging role in sickness and health
por: Marshall, Jack NG, et al.
Publicado: (2021)

MAO-B Polymorphism Associated with Progression in a Chinese Parkinson's Disease Cohort but Not in the PPMI Cohort
por: Cui, Shi-Shuang, et al.
Publicado: (2022)

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
por: Marek, Kenneth, et al.
Publicado: (2018)

Analysis of repetitive element expression in the blood and skin of patients with Parkinson’s disease identifies differential expression of satellite elements
por: Billingsley, Kimberley J., et al.
Publicado: (2019)

Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
por: Chen, Jia-Hung, et al.
Publicado: (2021)

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
por: Eusebi, Paolo, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021)

Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
por: Mihaescu, Alexander S., et al.
Publicado: (2022)

Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease
por: Gorecki, Anastazja M., et al.
Publicado: (2020)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

Motor subtypes and clinical characteristics in sporadic and genetic Parkinson's disease groups: analysis of the PPMI cohort
por: Jeong, Eun Hye, et al.
Publicado: (2023)

The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

Alteration of Tremor Dominant and Postural Instability Gait Difficulty Subtypes During the Progression of Parkinson's Disease: Analysis of the PPMI Cohort
por: Lee, Jeong Won, et al.
Publicado: (2019)

A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles
por: Cousineau, Martin, et al.
Publicado: (2017)

Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

Frequency and methylation status of selected retrotransposition competent L1 loci in amyotrophic lateral sclerosis
por: Savage, Abigail L., et al.
Publicado: (2020)

Mitochondrial DNA variation in Parkinson’s disease: Analysis of “out-of-place” population variants as a risk factor
por: Müller-Nedebock, Amica C., et al.
Publicado: (2022)

TOMM40‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

Genome-Wide Differential Transcription of Long Noncoding RNAs in Psoriatic Skin
por: Stacey, Valerie M., et al.
Publicado: (2023)

Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
por: Qin, Qixiong, et al.
Publicado: (2022)

The Prejudice towards People with Mental Illness (PPMI) scale: structure and validity
por: Kenny, Amanda, et al.
Publicado: (2018)

Predicting miRNA-disease associations based on PPMI and attention network
por: Xie, Xuping, et al.
Publicado: (2023)

Transcriptional Basis of Psoriasis from Large Scale Gene Expression Studies: The Importance of Moving towards a Precision Medicine Approach
por: Krishnan, Vidya S., et al.
Publicado: (2022)

Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF
por: Warburton, Alix, et al.
Publicado: (2015)

Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
por: Billingsley, Kimberley J., et al.
Publicado: (2019)

Non-coding genetic variation shaping mental health
por: Quinn, John P, et al.
Publicado: (2019)

Genomics of Wolfram Syndrome 1 (WFS1)
por: Kõks, Sulev
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5hbk3rv7d3aegbkm63hk46vmoo